In recent months, 2 genes were identified for the common form of hereditary colorectal cancer (hereditary non-polyposis colon cancer; HNPCC). Based on small numbers of highly selected families, as much as 90% of HNPCC might be attributable to these genes and carriers have an estimated 70-90% lifetime risk of colorectal cancer. However, HNPCC accounts for 4% or less of all colorectal cancers. The frequency of inherited MSH2 and MLH1 mutations is unknown among the other 96% of all colorectal cancers. Therefore, the aims of this population-based epidemiological study are to determine the frequencies of germline MSH2 and MLH1 mutations (carriers) in a population-based, stratified sample of 400 colorectal cancer patients randomly selected from the Cancer Surveillance Program of Orange, Imperial and San Diego Counties, California. Study subjects will be sampled from strata defined by family history of colorectal cancer (hereditary non-polyposis colon cancer, familial cases but not HNPCC, and sporadic cases), and age at cancer diagnosis (0-64 years, and 65 years and over). The results of mutational status (its presence or absence, and mutation site and type within the MSH2/MSH1 genes) will be correlated with data collated on family history, age at diagnosis, and RER status, as well as clinical, demographic and risk factor data from the questionnaire interview. The data from this population-based study will facilitate strategic planning for translation cancer control research that targets family members of subsets of colorectal cancer cases.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA067151-01
Application #
2110743
Study Section
Special Emphasis Panel (ZRG4-NTN (01))
Project Start
1995-04-01
Project End
1999-01-31
Budget Start
1995-04-01
Budget End
1996-01-31
Support Year
1
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02215
Zell, Jason A; Honda, Jane; Ziogas, Argyrios et al. (2008) Survival after colorectal cancer diagnosis is associated with colorectal cancer family history. Cancer Epidemiol Biomarkers Prev 17:3134-40
Zell, Jason A; McEligot, Archana J; Ziogas, Argyrios et al. (2007) Differential effects of wine consumption on colorectal cancer outcomes based on family history of the disease. Nutr Cancer 59:36-45
Zell, Jason A; Ignatenko, Natalia A; Yerushalmi, Hagit F et al. (2007) Risk and risk reduction involving arginine intake and meat consumption in colorectal tumorigenesis and survival. Int J Cancer 120:459-68
Peel, D J; Ziogas, A; Fox, E A et al. (2000) Characterization of hereditary nonpolyposis colorectal cancer families from a population-based series of cases. J Natl Cancer Inst 92:1517-22
Kolodner, R D; Tytell, J D; Schmeits, J L et al. (1999) Germ-line msh6 mutations in colorectal cancer families. Cancer Res 59:5068-74
Kane, M F; Loda, M; Gaida, G M et al. (1997) Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res 57:808-11
Kolodner, R (1996) Biochemistry and genetics of eukaryotic mismatch repair. Genes Dev 10:1433-42
Kolodner, R D (1995) Mismatch repair: mechanisms and relationship to cancer susceptibility. Trends Biochem Sci 20:397-401